Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 3
2006 8
2007 5
2008 5
2009 6
2010 7
2011 6
2012 2
2013 3
2014 4
2015 5
2016 5
2017 4
2018 7
2019 8
2020 7
2021 6
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human.
Morales-Cano D, Barreira B, Callejo M, Olivencia MA, Ferruelo A, Milara J, Lorente JÁ, Moreno L, Cogolludo Á, Perez-Vizcaino F. Morales-Cano D, et al. Among authors: cogolludo a. Vascul Pharmacol. 2024 Apr 8;155:107371. doi: 10.1016/j.vph.2024.107371. Online ahead of print. Vascul Pharmacol. 2024. PMID: 38599357
Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity.
Olivencia MA, Villegas-Esguevillas M, Sancho M, Barreira B, Paternoster E, Adão R, Larriba MJ, Cogolludo A, Perez-Vizcaino F. Olivencia MA, et al. Among authors: cogolludo a. Int J Mol Sci. 2023 Aug 2;24(15):12350. doi: 10.3390/ijms241512350. Int J Mol Sci. 2023. PMID: 37569725 Free PMC article.
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Morales-Cano D, Izquierdo-García JL, Barreira B, Esquivel-Ruiz S, Callejo M, Pandolfi R, Villa-Valverde P, Rodríguez I, Cogolludo A, Ruiz-Cabello J, Perez-Vizcaino F, Moreno L. Morales-Cano D, et al. Among authors: cogolludo a. Front Pharmacol. 2023 Jun 12;14:1228923. doi: 10.3389/fphar.2023.1228923. eCollection 2023. Front Pharmacol. 2023. PMID: 37377931 Free PMC article.
The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit.
Villegas-Esguevillas M, Cho S, Vera-Zambrano A, Kwon JW, Barreira B, Telli G, Navarro-Dorado J, Morales-Cano D, de Olaiz B, Moreno L, Greenwood I, Pérez-Vizcaíno F, Kim SJ, Climent B, Cogolludo A. Villegas-Esguevillas M, et al. Among authors: cogolludo a. Biomed Pharmacother. 2023 Aug;164:114952. doi: 10.1016/j.biopha.2023.114952. Epub 2023 Jun 7. Biomed Pharmacother. 2023. PMID: 37295249 Free article.
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Morales-Cano D, Izquierdo-García JL, Barreira B, Esquivel-Ruiz S, Callejo M, Pandolfi R, Villa-Valverde P, Rodríguez I, Cogolludo A, Ruiz-Cabello J, Perez-Vizcaino F, Moreno L. Morales-Cano D, et al. Among authors: cogolludo a. Front Pharmacol. 2023 Mar 29;14:1021535. doi: 10.3389/fphar.2023.1021535. eCollection 2023. Front Pharmacol. 2023. PMID: 37063275 Free PMC article.
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension.
Vera-Zambrano A, Lago-Docampo M, Gallego N, Franco-Gonzalez JF, Morales-Cano D, Cruz-Utrilla A, Villegas-Esguevillas M, Fernández-Malavé E, Escribano-Subías P, Tenorio-Castaño JA, Perez-Vizcaino F, Valverde D, González T; Spanish group of Ion Channels in Pulmonary Hypertension (SICPH) investigators; Cogolludo A. Vera-Zambrano A, et al. Among authors: cogolludo a. Am J Respir Cell Mol Biol. 2023 Aug;69(2):147-158. doi: 10.1165/rcmb.2022-0245OC. Am J Respir Cell Mol Biol. 2023. PMID: 36917789
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function.
Vera-Zambrano A, Baena-Nuevo M, Rinné S, Villegas-Esguevillas M, Barreira B, Telli G, de Benito-Bueno A, Blázquez JA, Climent B, Pérez-Vizcaino F, Valenzuela C, Decher N, Gonzalez T, Cogolludo A. Vera-Zambrano A, et al. Among authors: cogolludo a. Pharmacol Res. 2023 Mar;189:106684. doi: 10.1016/j.phrs.2023.106684. Epub 2023 Feb 3. Pharmacol Res. 2023. PMID: 36740150 Free article.
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities.
Kumar R, Aktay-Cetin Ö, Craddock V, Morales-Cano D, Kosanovic D, Cogolludo A, Perez-Vizcaino F, Avdeev S, Kumar A, Ram AK, Agarwal S, Chakraborty A, Savai R, de Jesus Perez V, Graham BB, Butrous G, Dhillon NK. Kumar R, et al. Among authors: cogolludo a. PLoS Pathog. 2023 Jan 12;19(1):e1011063. doi: 10.1371/journal.ppat.1011063. eCollection 2023 Jan. PLoS Pathog. 2023. PMID: 36634048 Free PMC article. Review.
Cardiac and Pulmonary Vascular Dysfunction in Vitamin D-Deficient Bmpr2-Mutant Rats.
Olivencia MA, Esquivel-Ruiz S, Callejo M, Mondéjar-Parreño G, Quintana-Villamandos B, Barreira B, Sacedón R, Cogolludo Á, Perros F, Mendes-Ferreira P, Pérez Vizcaíno F. Olivencia MA, et al. Among authors: cogolludo a. Am J Respir Cell Mol Biol. 2022 Sep;67(3):402-405. doi: 10.1165/rcmb.2022-0001LE. Am J Respir Cell Mol Biol. 2022. PMID: 36047774 No abstract available.
HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape.
Medrano-Garcia S, Morales-Cano D, Barreira B, Vera-Zambrano A, Kumar R, Kosanovic D, Schermuly RT, Graham BB, Perez-Vizcaino F, Mathie A, Savai R, Pullamseti S, Butrous G, Fernández-Malavé E, Cogolludo A. Medrano-Garcia S, et al. Among authors: cogolludo a. Cells. 2022 Aug 4;11(15):2414. doi: 10.3390/cells11152414. Cells. 2022. PMID: 35954255 Free PMC article.
95 results